Results 51 to 60 of about 4,080 (215)
, 2017 Periodontal diseases and dental diseases are proved as a significant role for Medication related osteonecrosis of the jaw(MRONJ) from many studies. But there has been no study of whether periodontal disease affects not only the onset of MRONJ but also ...
홍, 윤표
core +1 more source
Nasolabial Flaps in the Treatment of MRONJ
Surgical Case Reports, 2019 Medication-related osteonecrosis of the jaw (MRONJ) occurs as a side effect of several drug classes, including antiresorptives and antiangiogenics. Its treatment may be approached in a number of different ways. The report below outlines a notable surgical case wherein sequestrectomy (with the aid of fluorescence and a Visually Enhanced Lesion Scope ...
Nima Mahdian +3 more
openaire +1 more source
Oral Diseases, EarlyView.ABSTRACT Background Identification of healthy bone margins is a critical step in the surgical resective treatment of medication‐related osteonecrosis of the jaw (MRONJ). Fluorescence‐guided surgery (FGS) has been proposed as a method to identify resection margins and improve clinical outcomes.
Paolo De Angelis +6 more
wiley +1 more source
Alcohol-sensitivity and MRONJ in patients administered bone-modifying agents.
, 2022 MRONJ, medication-related osteonecrosis of the jaw.
Naoko Tanda (12769806) +5 more
core +1 more source
Frontiers in Oral Health, 2022 Medication-related osteonecrosis of the jaw (MRONJ) is a growing problem without an effective treatment, presenting as necrotic bone sections exposed via lesions in the overlying soft tissue.
George Bullock +4 more
doaj +1 more source
Combined Effects of Romosozumab and Zoledronate on the Development of Osteonecrosis of the Jaw
Oral Diseases, EarlyView.ABSTRACT Objective This study aimed to assess the occurrence of medication‐related osteonecrosis of the jaw (MRONJ) in mice following the sequential administration of romosozumab and zoledronate and to confirm their inhibitory effects on osteoclast differentiation in vitro.
Hae‐Seo Park +5 more
wiley +1 more source
Dentists' knowledge about medication-related osteonecrosis of the jaw and its management
Heliyon, 2020 Objectives: To assess the knowledge of dentists regarding medication-related osteonecrosis of the jaw (MRONJ). Methods: In this cross-sectional study, 74 dentists from governmental hospitals in Riyadh (Dental University Hospital in King Saud University ...
R. Al-Eid +3 more
doaj +1 more source
Medicina, 2023 Background and Objectives: Antiresorptive drugs are widely used in osteology and oncology. An important adverse effect of these drugs is medication-induced osteonecrosis of the jaw (MRONJ).
Matthias Troeltzsch +7 more
doaj +1 more source
Oral Health Screening Prior to Oncological Treatment—The Helsinki Protocol
Oral Diseases, EarlyView.ABSTRACT Objectives Oncological treatments can have adverse effects on oral health and cause long‐term complications such as osteonecrosis. This retrospective study investigated the oral health of head and neck cancer patients before radiotherapy and patients with multiple myeloma, breast, prostate, lung, and kidney cancers before antiresorptive ...
Jemina Järvinen +4 more
wiley +1 more source
OralOn 24 February 2024, Italian physicians, dentists and oral care specialists, students, nurses, psychologists, dental hygienists, and other professionals met (live or online) to discuss controversial issues about medication-related osteonecrosis of the ...
Vittorio Fusco +8 more
doaj +1 more source